Spero therapeutics appoints esther rajavelu as chief financial officer and chief business officer

Ms. rajavelu brings over two decades of experience in the life sciences sector focused on strategic growth, financing, m&a, and investor relations. ms. rajavelu brings over two decades of experience in the life sciences sector focused on strategic growth, financing, m&a, and investor relations.
SPRO Ratings Summary
SPRO Quant Ranking